Published: 30 April, 2020 | Volume 4 - Issue 1 | Pages: 001-008
Figure 4:
Liver GST (U/mg protein) of rat treated with nZnO, CP, and their combination. Significance at p > 0.05; Zinc oxide nanoparticles (nZnO); Cyclophosphamide: (CP). a Comparison of control and other groups, b Comparison of nZnO and other groups, c Comparison of CP and other groups, d Comparison of nZnO + CP and other groups, Means having the same letters are not significantly different.
Read Full Article HTML DOI: 10.29328/journal.ibm.1001016 Cite this Article Read Full Article PDF
HSPI: We're glad you're here. Please click "create a new Query" if you are a new visitor to our website and need further information from us.
If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click "take me to my Query."